St.Jude Medical adjusted profit rises

Oct 15 (Reuters) - Heart device maker St. Jude Medical Inc reported a lower quarterly profit, as it took a $39 million charge related to impairment and restructuring, despite a rise in sales of its devices to treat abnormal heart rhythms.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.